Public health value of universal HPV vaccination

  • Riccardo A. Audisio
  • , Giancarlo Icardi
  • , Andrea M. Isidori
  • , Carlo A. Liverani
  • , Alberto Lombardi
  • , Luciano Mariani
  • , Francesco Saverio Mennini
  • , David A. Mitchell
  • , Andrea Peracino
  • , Sergio Pecorelli
  • , Giovanni Rezza
  • , Carlo Signorelli
  • , Giovanni Rosati
  • , Gian Vincenzo Zuccotti

Research output: Contribution to journalArticlepeer-review

Abstract

Steps must be taken by relevant bodies to achieve the target of universal vaccination. The analysis of HPV vaccination's clinical effectiveness vs. economic efficacy are supportive of the economic sustainability of vaccination programs both in women and men. In Europe, these achievements demand urgent attention to the social equity for both genders in healthcare. There is sufficient ethical, scientific, strategic and economic evidence to urge the European Community to develop and implement a coordinated and comprehensive strategy aimed at both genders and geographically balanced, to eradicate cervical cancer and other diseases caused by HPV in Europe. Policymakers must take into consideration effective vaccination programs in the prevention of cancers.
Original languageEnglish
Pages (from-to)157-167
JournalCritical Reviews in Oncology/Hematology
Volume97
DOIs
Publication statusPublished - Jan 2016
Externally publishedYes

Keywords

  • Allied health professions and studies

Fingerprint

Dive into the research topics of 'Public health value of universal HPV vaccination'. Together they form a unique fingerprint.

Cite this